Assembly Biosciences ASMB Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | -$38.55M+1.1% | -$38.96M+2.4% | -$39.92M+0.6% | ||
| $122K-5.4% | $129K0.0% | $129K-0.8% | $130K0.0% | $130K+0.8% | ||
| $5.08M+8.6% | $4.68M+17.9% | $3.97M+28.2% | $3.09M0.0% | $3.09M-0.9% | ||
| —— | —— | -$55.74M+0.2% | -$55.85M+0.6% | -$56.19M-9.9% | ||
| $85K+28.8% | $66K— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $172.89M-1.0% | $174.67M-8.6% | $191.21M+892% | $19.27M-38.6% | $31.37M+6.5% | ||
| $7.71M-61.7% | $20.11M+440% | -$5.92M-223% | $4.8M+2.9% | $4.66M-74.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Assembly Biosciences generate?
- Assembly Biosciences (ASMB) generated -$77.4M in operating cash flow over the trailing twelve months.
- What is Assembly Biosciences's free cash flow?
- After $85.0K of capital expenditures, Assembly Biosciences's free cash flow was -$77.5M over the trailing twelve months, down 51.5% year over year.
- Where does Assembly Biosciences's cash flow data come from?
- Every line is extracted from Assembly Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
